OncoQuest aims to enhance the success of cancer immunotherapy

This Canadian biotechnology company is developing combination-treatment strategies based on monoclonal antibodies to improve clinical outcomes for cancer patients. To download the full article, please sign in.

Mar 01, 2016
2
0
Page of

OncoQuest Inc

Canadian biotechnology company developing combination-treatment strategies based on monoclonal antibodies to improve clinical outcomes for cancer patients.

No comments yet.